| |
Newsroom /
Health and Fitness
/
Healthcare
/
Cancer Vaccines – Drug Pipeline Analysis and Market Forecasts to 2016
Cancer Vaccines – Drug Pipeline Analysis and Market Forecasts to 2016
The Global Cancer Vaccines Therapeutics Market is Forecast to Show Increased Growth Until 2016
Hyderabad,
AP,
India
(prbd.net)
25/01/2010
"Cancer Vaccines – Drug Pipeline Analysis and Market Forecasts to 2016"
GlobalData has estimated that the global cancer vaccines market in 2009 was worth $1.8 billion. There are currently two products, which constitute the global cancer vaccines market. These are Gardasil and Cervarix used for the treatment of cervical cancer. Oncophage has also been approved for kidney cancer but only in Russia. Hence the market forecasts do not include this vaccine. The present pipeline for cancer vaccines seems to be very promising with numerous molecules present in the Phase II and III stages. From the market perspective, there are going to be multiple launches of vaccines between 2010 and 2013-14, which would substantially increase the market size and growth. The cost of three complete dose courses of the vaccines ranges approximately from $380 to $400.
The present global cancer vaccines market is occupied by cervical cancer vaccines. Except for the presence of these prophylactic cervical cancer vaccines, the market has no therapeutic vaccines to treat the existing condition. The launch of these prophylactic vaccines has renewed interest in the development of vaccines for cancer. Though the therapeutic vaccines were in the pipeline for a long period, none of them has managed to cross the regulatory hurdles and receive approval in the decisive US and EU markets. Manufacturers have faced trouble proving the efficacy and safety of these vaccines along with demanding manufacturing guidelines. The market has fewer options for prevention and none for treatment currently. The market is waiting for a paradigm shift in the treatment of cancer through the introduction of new therapeutic vaccines that have a more targeted approach.
GlobalData, the industry analysis specialist, has released its latest research “Cancer Vaccines - Drug Pipeline Analysis and Market Forecasts to 2016”. It provides key data, information and analysis on the global Cancer vaccines market. The report provides a comprehensive overview of annualized market data from 2001 to 2009, and forecasts for the next seven years to 2016. The report covers the market landscape, market drivers and restraints, and an in-depth pipeline analysis. The current competitive landscape is analyzed along with the prevailing unmet need or commercial opportunities of the market. The pipeline analysis covers molecules across all phases of clinical development and gives an overview of the developing trends among pipeline molecules, as well as, an insight into the most promising pipeline drugs, supplemented with key company profiles. By considering the current competition in the market and the prospects of the pipeline molecules, the resulting implications for future market competition is also outlined.
Or Visit our report store: http://www.globaldata.com/reportstore
About
GlobalData is a global market intelligence services company providing information research and analysis products and services.
|